Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 618-624 , December 2009

DCEMRI of spontaneous canine tumors during fractionated radiotherapy: A pharmacokinetic analysis

  • Åste Søvik

      Affiliations

    • Department of Radiation Biology, Oslo University Hospital, Oslo, Norway
    • Department of Companion Animal Clinical Sciences, The Norwegian School of Veterinary Science, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310 Oslo, Norway.
  • ,
  • Hege Kippenes Skogmo

      Affiliations

    • Department of Companion Animal Clinical Sciences, The Norwegian School of Veterinary Science, Oslo, Norway
  • ,
  • Erlend K.F. Andersen

      Affiliations

    • Department of Physics, University of Oslo, Oslo, Norway
    • Department of Medical Physics, Oslo University Hospital, Oslo, Norway
  • ,
  • Øyvind S. Bruland

      Affiliations

    • Department of Companion Animal Clinical Sciences, The Norwegian School of Veterinary Science, Oslo, Norway
    • Department of Oncology, Oslo University Hospital, Oslo, Norway
    • Faculty of Clinical Medicine, University of Oslo, Oslo, Norway
  • ,
  • Dag Rune Olsen

      Affiliations

    • Department of Radiation Biology, Oslo University Hospital, Oslo, Norway
    • Department of Physics, University of Oslo, Oslo, Norway
  • ,
  • Eirik Malinen

      Affiliations

    • Department of Medical Physics, Oslo University Hospital, Oslo, Norway

Received 17 February 2009 ,Revised 28 July 2009 ,Accepted 4 August 2009.

References 

  1. Chapman JD, Bradley JD, Eary JF, et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys. 2003;55:294–301
  2. Rajendran JG, Mankoff DA. Beyond detection: novel applications for PET imaging to guide cancer therapy. J Nucl Med. 2007;48:855–856
  3. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16:407–422
  4. Weber WA. PET for response assessment in oncology: radiotherapy and chemotherapy. Br J Radiol. 2005;S28:42–47
  5. Sovik A, Malinen E, Skogmo HK, Bentzen SM, Bruland OS, Olsen DR. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys. 2007;68:1496–1504
  6. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74
  7. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509–520
  8. Jackson A, O’Connor JP, Parker GJ, Jayson GC. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res. 2007;13:3449–3459
  9. Larsson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood–brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med. 1990;16:117–131
  10. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621–628
  11. Tofts PS, Kermode AG. Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17:357–367
  12. Sovik A, Kippenes SH, Bruland OS, Rune OD, Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol. 2008;47:1249–1256
  13. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101
  14. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
  15. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood–tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging. 1999;10:233–241
  16. van Osch MJ, Vonken EJ, Viergever MA, van der GJ, Bakker CJ. Measuring the arterial input function with gradient echo sequences. Magn Reson Med. 2003;49:1067–1076
  17. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res. 1998;4:2305–2312
  18. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54:759–767
  19. Zahra MA, Tan LT, Priest AN, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766–773
  20. Hawighorst H, Engenhart R, Knopp MV, et al. Intracranial meningiomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging. 1997;15:423–432
  21. Oberholzer K, Pohlmann A, Schreiber W, et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging. 2008;27:1296–1301
  22. Rose CJ, Mills S, O’Connor JP, et al. Quantifying heterogeneity in dynamic contrast-enhanced MRI parameter maps. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2007;10:376–384
  23. Devries AF, Griebel J, Kremser C, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61:2513–2516

PII: S0167-8140(09)00448-4

doi: 10.1016/j.radonc.2009.08.012

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 618-624 , December 2009